Skip to main content
Log in

Kavapyrone enriched extract fromPiper methysticum as modulator of the GABA binding site in different regions of rat brain

  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Regional differences in the modulation of [3H] muscimol binding to GABAA receptor complexes by kavapyrones, compounds of the rhizome of the plantPiper methysticum which possess sedative activity, were demonstrated using membrane fractions obtained from target brain centers of kavapyrone action: hippocampus (HIP), amygdala (AMY) and medulla oblongata (MED), and from brain centers outside the main kavapyrone effects as frontal cortex (FC) and cerebellum (CER). The kava extract enhanced the binding of [3H] muscimol in a concentration-dependent manner with maximal potentiation of 358% over control in HIP followed by AMY and MED (main target brain centers). Minimal stimulation was observed in CER followed by FC. In contrast, apart from CER, the potency of kavapyrones was similar in the brain areas investigated with EC50 values ranging between 200 and 300 µM kavapyrones. Scatchard analysis revealed that the observed effects of kavapyrones were due to an increase in the number of binding sites (Bmax), rather than to a change in affinity. At a kavapyrone concentration of 500 µM the order of enhancement in Bmax was HIP=AMY>MED>FC>CER. When kavapyrones are included together with pentobarbital or HPO the two classes of compounds produced a more than additive, i.e., synergetic effect on [3H] muscimol binding. Our findings suggest that one way kavapyrones might mediate sedative effects in vivo is through effects on GABAA receptor binding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Backhauß C, Krieglstein J (1992) Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 215:265–269

    Google Scholar 

  • Buckley JP, Furgiuele AR, O'Hara MJ (1967) Pharmacology of kava. In: Efron KH, Holmstedt B, Kline NS (eds) Ethnopharmacology search for psychoactive drugs. Raven Press, New York pp 141–151

    Google Scholar 

  • Davis LP, Drew CA, Duffield P, Johnston GAR, Jamieson DD (1992) Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol 71:120–126

    Google Scholar 

  • Diaz-Arauzo H, Koehler KF, Hagen TJ, Cook J (1991) Synthetic and computer assisted analysis of the pharmacophore for agonists at benzodiazepine receptors. Life Sci 49:207–216

    Google Scholar 

  • Holm U, Staedt U, Heep J, Kortsik C, Behne F, Kaske A, Mennicke I (1991) Studies on the profile of neurophysiological effects of D,L-kavain/cerebral sites of action and sleep-wakefulnessrhythm in animals. Drug Res 41 [II]:673–683

    Google Scholar 

  • Jussofie A (1993a) A new highly sensitive procedure-a prerequisite to evaluate the density of GABAA receptors and to study their allosteric properties in distinct areas of rat brain. Biol Chem Hoppe-Seyler 374:61–68

    Google Scholar 

  • Jussofie A (1993b) Brain region-specific effects of neuroactive steroids on the affinity and density of the GABA-binding site. Biol Chem Hoppe-Seyler 374:265–270

    Google Scholar 

  • Jussofie A (1993c) Brain area specific differences in the effects of neuroactive steroids on the GABAA receptor complexes following acute treatment with anaesthetically active steroids. Acta Endocrinol 129:480–485

    Google Scholar 

  • Keledjian J, Duffield PH, Jamieson DD, Lidgard RO, Duffield AM (1988) Uptake into mouse brain of four compounds present in the psychoactive beverage kava. J Pharm Sci 77:1003–1006

    Google Scholar 

  • Keller F, Klohs MW (1963) A review of the chemistry and pharmacology of the constituents ofPiper methysticum. Lloydia 26:1–15

    Google Scholar 

  • Klohs MW, Keller F, Williams RE, Tokes M, Cronheim GE (1959) A Chemical and pharmacological investigation ofPiper methysticum Forst. J Med Pharm Chem 1:95–103

    Google Scholar 

  • Kretzschmar R, Teschendorf HJ (1974) Pharmacologische Untersuchungen zur sedativ-tranquilisierenden Wirkung des Rauschpfeffers (Piper Methysticum Forst.) Chemiker-Zeitung 98:24–28

    Google Scholar 

  • Kretzschmar R, Teschendorf HJ, Ladous A, Ettehadieh D (1971) On the sedative action of the kava rhizome (piper methyst). Acta Pharmacol Toxicol 29 [suppl. 4]:26

    Google Scholar 

  • Koenig JA, Martin IL (1992) Effect of free fatty acids on GABAA receptor ligand binding. Biochem Pharmacol 44:11–153

    Google Scholar 

  • Laurie DJ, Seeburg PH, Wisden W (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. olfactory bulb and cerebellum. J Neurosci 12:1063–1076

    Google Scholar 

  • Liljequist S, Tabakoff B (1993) Bicuculline-produced regional differences in the modulation of35S-TBPS binding by GABA, pentobarbital and diazepam in mouse cerebellum and cortex. J Pharmacol Exp Ther 264:638–647

    Google Scholar 

  • Majewska DM (1992) Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurosci 38:379–395

    Google Scholar 

  • Massotti M, Schlichting JL, Antonacci MD, Giusti P, Memo M, Costa E, Guidotti A (1991) Gamma-aminobutyric acidA receptor heterogeneity in rat central nervous system: studies with clonazepam and other benzodiazepine ligands. J Pharmacol Exp Ther 256:1154–1160

    Google Scholar 

  • Meyer HJ (1962) Pharmakologie der wirksamen Prinzipien des Kava-Rhizoms. Arch Int Pharmacodyn 138:505–536

    Google Scholar 

  • Meyer HJ (1979) Pharmacology of kava. In: Efron KH, Holmstedt B, Kline N (eds) Ethnopharmacology search for psychoactive drugs. Raven Press, New York, pp 133–140

    Google Scholar 

  • Miller KW (1985) The nature of the site of general anesthesia. Int Rev Neurobiol 27:1–61

    Google Scholar 

  • Olsen RW, Snowman AM (1982) Chloride-dependent enhancement by barbiturates of gamma-aminobutyric acid receptor binding. J Neurosci 2:1812–1823

    Google Scholar 

  • Olsen RW, Tobin AJ (1990) Molecular biology of GABAA receptors. FASEB J 4:1469–1480

    Google Scholar 

  • Peters JA, Kirkness EF, Callachan J, Lambert JJ, Turner AJ (1988) Modulation of the GABAA receptor by depressant barbiturates and pregnane steroids. Br J Pharmacol 94:1257–1269

    Google Scholar 

  • Rasmussen AK, Scheline RR, Solheim E (1979) Metabolism of some kavapyrones in rat. Xenobiotica 9:1–16

    Google Scholar 

  • Sapp DW, Witte U, Turner DM, Longoni B, Kokka N, Olsen RW (1992) Regional variation in steroid anesthetic modulation of [35S] TBPS binding to gamma-aminobutyric acidA receptors in rat brain. J Pharmacol Exp Ther 262:801–808

    Google Scholar 

  • Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:600–672

    Google Scholar 

  • Schumacher M, McEwen BS (1989) Steroid and barbiturate modulation of the GABAa receptor. Mol Neurobiol 3:275–304

    Google Scholar 

  • Sieghart W (1992) GABAA receptors: ligand-gated Cl ion channels modulated by multiple drug-binding sites. Trends Biochem Sci 13:146–150

    Google Scholar 

  • Simmonds MA, Turner JP (1987) Potentiators of responses to activation of gamma-aminobutyric acid (GABAA) receptors. Neuropharmacology 26:923–930

    Google Scholar 

  • Spree MH, Croy H-H (1992) Antares-ein standardisiertes Kava-Kava-Präparat mit dem Spezialextrakt KW 1491, Der Kassenarzt (Deutsches Ärztemagazin) 17:44–51. Stephenson FA (1988) Understanding the GABAA receptor: a chemically gated ion-channel. Biochem J 249:21–32

    Google Scholar 

  • Study RE, Barker JL (1981) Diazepam and pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 78:7180–7184

    Google Scholar 

  • Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. telencephalon, diencephalon, mesencephalon. J Neurosci 12:1063–1076

    Google Scholar 

  • Yang JSF, Olsen RW (1987) Gamma-amino-butyric acid receptor binding in fresh mouse brain membranes at 22°C: ligand-induced changes in affinity. Mol Pharmacol 32:266–277

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This paper contains essential parts of the dissertation by Annette Schmiz

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jussofie, A., Schmiz, A. & Hiemke, C. Kavapyrone enriched extract fromPiper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology 116, 469–474 (1994). https://doi.org/10.1007/BF02247480

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02247480

Key words

Navigation